GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Azenta Inc (LTS:0HQ1) » Definitions » Inventories, Other

Azenta (LTS:0HQ1) Inventories, Other : $0.0 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Azenta Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Azenta's other inventories for the quarter that ended in Dec. 2024 was $0.0 Mil.

Azenta's annual other inventories increased from Sep. 2022 ($-0.0 Mil) to Sep. 2023 ($0.0 Mil) but then declined from Sep. 2023 ($0.0 Mil) to Sep. 2024 ($0.0 Mil).


Azenta Inventories, Other Historical Data

The historical data trend for Azenta's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Azenta Inventories, Other Chart

Azenta Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Azenta Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Azenta Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Azenta Business Description

Traded in Other Exchanges
Address
200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

Azenta Headlines

No Headlines